Literature DB >> 16524358

Medication costs as a primary cause of nonadherence in the elderly.

Tom Lynch1.   

Abstract

Many elderly enrolling in the Medicare Part D prescription drug benefit, which began January 1, 2006, have low annual incomes and few countable assets. Although some are eligible for special assistance to pay for prescription medications, many others will still have significant out-of-pocket expenses while enrolled. The inability to pay for medications is an important cause of nonadherence in the elderly and has been associated with an increase in adverse drug events, acute hospitalizations, and nursing home admissions. This case describes a 77-year-old woman residing in a retirement community who was failing to respond to drug therapy for her hypertension and diabetes. The physician was unaware of her inability to pay for medications, and the patient was too embarrassed to discuss the issue. The case demonstrates some of the techniques that a pharmacist can use to adjust a patient's medication regimen to reduce the cost load, improve adherence, and maintain treatment goals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16524358     DOI: 10.4140/tcp.n.2006.143

Source DB:  PubMed          Journal:  Consult Pharm        ISSN: 0888-5109


  4 in total

1.  Impact of depression and anxiety disorders on adherence to oral hypoglycemics in older adults with diabetes mellitus in Canada.

Authors:  Lia Gentil; Helen-Maria Vasiliadis; Djamal Berbiche; Michel Préville
Journal:  Eur J Ageing       Date:  2016-07-23

Review 2.  Challenges of treatment adherence in older patients with Parkinson's disease.

Authors:  Jacquelyn L Bainbridge; J Mark Ruscin
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

3.  Out of Pocket Payment and Affordability of Medication for Geriatric Patients in Tehran, Iran.

Authors:  Morvarid Zarif-Yeganeh; Mona Kargar; Arash Rashidian; Aarefeh Jafarzadeh Kohneloo; Kheirollah Gholami
Journal:  Iran J Public Health       Date:  2019-06       Impact factor: 1.429

Review 4.  Comprehensive cardiovascular risk management--what does it mean in practice?

Authors:  Leif Erhardt; Robert Moller; Juan García Puig
Journal:  Vasc Health Risk Manag       Date:  2007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.